
Inhaler prescribing errors: Identifying risks and improving patient safety
Home » Case studies » Inhaler prescribing errors: Identifying risks and improving patient safety
We improved patient safety and raised awareness across GPs, hospitals and community pharmacy of the risks of prescribing inhalers containing duplicate ingredients from the same drug group by identifying patients who were prescribed and using duplicate inhalers and highlighting the side effects this caused.
Read the full case study
For more information
For more information and to learn how we can help your organisation, please contact us.